[1]
Khosravi, A., Farzadfard, M.-T. and Abdollahpour, A. 2017. Frequency of stroke patients qualified for recombinant tissue plasminogen activator (r-TPA) injection and limitations in Zahedan 2016. International Journal of Basic & Clinical Pharmacology. 7, 1 (Dec. 2017), 7–10. DOI:https://doi.org/10.18203/2319-2003.ijbcp20175670.